M&A Deal Summary

Imunon Acquires Egen

On June 20, 2014, Imunon acquired life science company Egen from Greer Capital Advisors

Acquisition Highlights
  • This is Imunon’s 1st transaction in the Life Science sector.
  • This is Imunon’s 1st transaction in the United States.
  • This is Imunon’s 1st transaction in Alabama.

M&A Deal Summary
Date 2014-06-20
Target Egen
Sector Life Science
Buyer(s) Imunon
Sellers(s) Greer Capital Advisors
Deal Type Add-on Acquisition

Target

Egen

Huntsville, Alabama, United States
Egen, Inc., operates biopharmaceutical company focused on developing nucleic acid-based therapeutics for cancer and other difficult to treat diseases using proprietary nanoparticle delivery systems. Egen was founded in 2002 and is based in Huntsville, Alabama.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Imunon

Lawrenceville, New Jersey, United States
Category Company
Founded 1982
Sector Life Science
Employees33
DESCRIPTION

Imunon is an operator of biopharmaceutical company focused on developing a portfolio of innovative cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy, and RNA-based therapies. Imunon was founded in 1982 and is based in Lawrenceville, New Jersey.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Alabama) 1 of 1
Country (United States) 1 of 1
Year (2014) 1 of 1

Seller(S) 1

SELLER

Greer Capital Advisors

Mountain Brook, Alabama, United States

Investor

Category Private Equity Firm
Founded 2002
Size Small
Type Sector Focused
DESCRIPTION

Greer Capital Advisors (GCA) is a specialized, heathcare focused private equity firm that targets investments in Alabama based companies. Within healthcare, GCA looks for companies in the pharmaceutical, biotechnology, medical device, and diagnostics industries. GCA prefers early and growth stage investments and generally seeks to invest between $1 to $2 million per transaction. Greer Capital Advisors was formed in 2002 and is based in Birmingham, Alabama.

DEAL STATS #
Overall 12 of 13
Sector (Life Science) 9 of 10
Type (Add-on Acquisition) 9 of 10
State (Alabama) 6 of 7
Country (United States) 12 of 13
Year (2014) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-12-04 Vidacare

Shavano Park, Texas, United States

Vidacare Corp. is a provider of intraosseous (IO), or inside the bone access devices.

Sell $263M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-11-28 BioDtech

Birmingham, Alabama, United States

BioDtech, Inc. develops and markets products for the detection, neutralization, and removal of biological toxins for pharmaceutical manufacturing and clinical applications. BioDtech was founded in 2003 and is based in Birmingham, Alabama.

Sell -
Mergr

Product

Company

Legal